skirtangle4
About
Necessary protein kinase D inhibitor moored BRD4 PROTAC PEGylated nanoliposomes for the treatment vemurafenib-resistant most cancers.
Necessary protein kinase D inhibitor moored BRD4 PROTAC PEGylated nanoliposomes for the treatment vemurafenib-resistant most cancers.